Zevra therapeutics to report third quarter 2024 financial results and provide corporate update on nov. 12, 2024

Celebration, fla., oct. 31, 2024 (globe newswire) -- zevra therapeutics, inc. (nasdaqgs: zvra) (zevra, or the company), a commercial-stage company focused on addressing unmet needs for the treatment of rare diseases, today announced it will report third quarter financial results and provide a corporate update on tuesday, nov. 12, 2024.
ZVRA Ratings Summary
ZVRA Quant Ranking